TELA Bio, Inc.
TELA
$0.9596
-$0.0124-1.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.56% | 29.34% | 31.64% | 40.03% | 41.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.56% | 29.34% | 31.64% | 40.03% | 41.13% |
| Cost of Revenue | 24.89% | 33.34% | 31.11% | 34.10% | 32.36% |
| Gross Profit | 15.75% | 27.61% | 31.87% | 42.79% | 45.40% |
| SG&A Expenses | 6.44% | 21.69% | 25.25% | 28.41% | 30.56% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | -53.83% | -52.74% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.26% | 21.16% | 23.91% | 26.73% | 27.48% |
| Operating Income | 5.40% | -10.63% | -14.54% | -11.90% | -12.99% |
| Income Before Tax | 18.60% | 5.10% | 3.22% | 11.36% | -5.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.91% | 5.10% | 3.22% | 11.36% | -5.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.91% | 5.10% | 3.22% | 11.36% | -5.35% |
| EBIT | 5.40% | -10.63% | -14.54% | -11.90% | -12.99% |
| EBITDA | 5.97% | -10.72% | -14.79% | -13.35% | -14.40% |
| EPS Basic | 32.64% | 18.07% | 23.82% | 37.33% | 25.78% |
| Normalized Basic EPS | 17.54% | 3.09% | 10.12% | 23.31% | 23.46% |
| EPS Diluted | 32.75% | 18.19% | 23.93% | 37.40% | 25.75% |
| Normalized Diluted EPS | 17.54% | 3.09% | 10.12% | 23.31% | 23.46% |
| Average Basic Shares Outstanding | 24.75% | 14.37% | 25.37% | 38.95% | 40.58% |
| Average Diluted Shares Outstanding | 24.75% | 14.37% | 25.37% | 38.95% | 40.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |